Efficiency of carcinogenesis: is the mutator phenotype inevitable?
Beckman
Robert A
RA
Department of Oncology Clinical Research, Daiichi Sankyo Pharmaceutical Development, Edison, NJ 08837, USA. eniac1@snip.net